These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 719671)

  • 1. [Prevention of viral hepatitis in the blood transfusion services of the USSR and Czechoslovakia. Significance of screening tests for hepatitis B antigens and transaminases].
    Golosová TV; Burlev VA; Margolina AN; Horejsí J; Novák J; Kselíková M; Urbánková J
    Cas Lek Cesk; 1978 Oct; 117(40):1241-3. PubMed ID: 719671
    [No Abstract]   [Full Text] [Related]  

  • 2. [Decrease of transfusion hepatitis following introduction of transaminases and Australia (SH)-antigen determination in blood donors].
    Arndt HJ; Frese R; Nachtwey K; Loos W; Kaboth U; Creutzfeldt W
    Dtsch Med Wochenschr; 1971 Aug; 96(34):1371-2. PubMed ID: 4998053
    [No Abstract]   [Full Text] [Related]  

  • 3. [Importance of screening tests for hepatitis B antigen and transaminase in blood service institutions for the prevention of viral hepatitis].
    Golosova TV; Burlev VA; Margolina AN; Gorzejsi I; Novák J
    Probl Gematol Pereliv Krovi; 1979 Mar; 24(3):47-8. PubMed ID: 372947
    [No Abstract]   [Full Text] [Related]  

  • 4. [Present status and future of serum hepatitis].
    Watanuki T
    Geka Chiryo; 1971 Mar; 24(3):334-42. PubMed ID: 5107993
    [No Abstract]   [Full Text] [Related]  

  • 5. Australia antigen and post transfusion hepatitis.
    Berthold H; Kleine N; Büttner G; Müller G
    Prog Immunobiol Stand; 1971; 5():63-6. PubMed ID: 4633979
    [No Abstract]   [Full Text] [Related]  

  • 6. Hepatitis-associated antigen tests for all donor blood now required.
    R I Med J; 1972 Mar; 55(3):85-6. PubMed ID: 4502029
    [No Abstract]   [Full Text] [Related]  

  • 7. Prevention of viral hepatitis.
    Grady GF
    Can Med Assoc J; 1972 Feb; 106(Spec Issue):Suppl:453-5. PubMed ID: 4111524
    [No Abstract]   [Full Text] [Related]  

  • 8. [Australia antigen and transfusion hepatitis. A prospective study on the frequency and prevention of transfusion hepatitis].
    Berthold H; Kleine N; Müller G
    Zentralbl Bakteriol Orig A; 1972 May; 220(1):230-4. PubMed ID: 4145571
    [No Abstract]   [Full Text] [Related]  

  • 9. [Contemporary problems of blood donation].
    Lipats AA
    Probl Gematol Pereliv Krovi; 1974 Sep; 19(9):6-10. PubMed ID: 4459942
    [No Abstract]   [Full Text] [Related]  

  • 10. [Prevention of transmission of viral hepatitis by blood derivatives by regular screening for Australia antigen (Au-HAA)].
    Novák J; Urbánková J
    Cas Lek Cesk; 1972; 111(18):409-12. PubMed ID: 5023513
    [No Abstract]   [Full Text] [Related]  

  • 11. [Decrease in the occurrence of transfusion hepatitis in Göttingen hospitals following the introduction of routine transaminase and Australia antigen determination in blood donors].
    Arndt HJ; Frese R; Nachtwey K; Loos W; Kaboth U; Creutzfeldt W
    Verh Dtsch Ges Inn Med; 1971; 77():1193-5. PubMed ID: 5155989
    [No Abstract]   [Full Text] [Related]  

  • 12. Prevalence of HB Ag and HB Ab in the Canadian blood-donor population.
    Moore BP
    Haematologia (Budap); 1974; 8(1-4):409-13. PubMed ID: 4461428
    [No Abstract]   [Full Text] [Related]  

  • 13. [Etiology, diagnosis and the prospects for vaccinal prevention hepatitis B].
    Anan'ev VA
    Vestn Akad Med Nauk SSSR; 1983; (12):37-40. PubMed ID: 6229935
    [No Abstract]   [Full Text] [Related]  

  • 14. [Current status of hepatitis B prevention].
    Rosmanith P; Schönitzer D
    Infusionsther Klin Ernahr; 1985 Aug; 12(4):192-5. PubMed ID: 2933329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study of blood transaminases in blood donors in the prevention of post-transfusion virus hepatitis].
    Teofili T; Tucci G
    Ann Med Nav (Roma); 1969; 74(1):31-43 contd. PubMed ID: 5405058
    [No Abstract]   [Full Text] [Related]  

  • 16. Screening of HBsAg and post-transfusional hepatitis type B.
    Bedarida G; D'Agostino F; Lavezzi C; Tamagni F
    Boll Ist Sieroter Milan; 1978 May; 57(2):160-4. PubMed ID: 728267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hepatitis B--significance for transfusion medicine].
    Jilg W
    Infusionsther Transfusionsmed; 1994 Aug; 21 Suppl 1():20-6. PubMed ID: 8000250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Concerning the value of hepatitis B antigen recovery for prevention of post-transfusion hepatitis (author's transl)].
    Krislo V; Masek O
    Bratisl Lek Listy; 1980 Aug; 74(2):223-8. PubMed ID: 7407658
    [No Abstract]   [Full Text] [Related]  

  • 19. [Prevention of viral hepatitis type B in transfusion of blood and its components].
    Golosova TV
    Sov Med; 1975 Sep; (9):139-43. PubMed ID: 1231018
    [No Abstract]   [Full Text] [Related]  

  • 20. Seroconversion from hepatitis B e antigen to anti-HBe in chronic hepatitis B virus infection.
    Realdi G; Alberti A; Rugge M; Bortolotti F; Rigoli AM; Tremolada F; Ruol A
    Gastroenterology; 1980 Aug; 79(2):195-9. PubMed ID: 7399226
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.